These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20664182)

  • 21. Gene profiling after knocking-down expression of nucleostemin in Hela cells using oligonucleotide DNA microarray.
    Liu SJ; Zhang ZH; Zhang DQ; Sui XM; Liu YJ; Cai ZW; Yuan XY; Sun LQ; Hu GF; Liu RL
    J Exp Clin Cancer Res; 2006 Dec; 25(4):575-83. PubMed ID: 17310849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.
    Sun B; Zhang X; Yonz C; Cummings BS
    Biochem Pharmacol; 2010 Jun; 79(12):1727-35. PubMed ID: 20171194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of prostate specific antigen (PSA) is negatively regulated by p53.
    Gurova KV; Roklin OW; Krivokrysenko VI; Chumakov PM; Cohen MB; Feinstein E; Gudkov AV
    Oncogene; 2002 Jan; 21(1):153-7. PubMed ID: 11791186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
    Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.
    Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S
    J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
    Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
    Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Silencing effect of cell-specific RNA interference plasmid pPSMAe/p-shNS-ploy(A) loaded by transgenic vector Tf-PEG-PEI targeting nucleostemin on prostate cancer cells in vitro].
    Liu RL; Wang WY; Zhang ZH; Xu Y
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):725-9. PubMed ID: 23291063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nucleolar GTP-binding proteins Gnl2 and nucleostemin are required for retinal neurogenesis in developing zebrafish.
    Paridaen JT; Janson E; Utami KH; Pereboom TC; Essers PB; van Rooijen C; Zivkovic D; MacInnes AW
    Dev Biol; 2011 Jul; 355(2):286-301. PubMed ID: 21565180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth.
    Han B; Izumi H; Yasuniwa Y; Akiyama M; Yamaguchi T; Fujimoto N; Matsumoto T; Wu B; Tanimoto A; Sasaguri Y; Kohno K
    Biochem Biophys Res Commun; 2011 Apr; 408(1):45-51. PubMed ID: 21453679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway.
    Ma H; Pederson T
    Mol Biol Cell; 2007 Jul; 18(7):2630-5. PubMed ID: 17494866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key pathways involved in prostate cancer based on gene set enrichment analysis and meta analysis.
    Ning QY; Wu JZ; Zang N; Liang J; Hu YL; Mo ZN
    Genet Mol Res; 2011 Dec; 10(4):3856-87. PubMed ID: 22194210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of NB4 cells following knockdown of nucleostemin using DNA microarrays.
    Sun X; Jia Y; Wei Y; Liu S; Yue B
    Mol Med Rep; 2016 Jul; 14(1):175-83. PubMed ID: 27374947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro study of nucleostemin as a potential therapeutic target in human breast carcinoma SKBR-3 cells.
    Guo Y; Liao YP; Zhang D; Xu LS; Li N; Guan WJ; Liu CQ
    Asian Pac J Cancer Prev; 2014; 15(5):2291-5. PubMed ID: 24716972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
    Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
    Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner.
    Jafarnejad SM; Mowla SJ; Matin MM
    Cell Prolif; 2008 Feb; 41(1):28-35. PubMed ID: 18211284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of Nucleostemin in an ovarian cancer SKOV-3 cell line and its effects on cell malignancy.
    Wang J; Wang L; Ji Q; Zhu H; Han S
    Biochem Biophys Res Commun; 2017 May; 487(2):262-267. PubMed ID: 28412352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.
    Asadi MH; Derakhshani A; Mowla SJ
    Tumour Biol; 2014 Jul; 35(7):7177-85. PubMed ID: 24763828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro study of Nucleostemin gene as a potential therapeutic target for human lung carcinoma.
    Gao HX; Gao XF; Wang GQ; Wang ES; Huang W; Huang P
    Biomed Environ Sci; 2012 Feb; 25(1):91-7. PubMed ID: 22424632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLF1 interacting protein: a potential gene therapy target for human prostate cancer?
    Zhang L; Ji G; Shao Y; Qiao S; Jing Y; Qin R; Sun H; Shao C
    Med Oncol; 2015 Feb; 32(2):454. PubMed ID: 25572810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleophosmin is a binding partner of nucleostemin in human osteosarcoma cells.
    Ma H; Pederson T
    Mol Biol Cell; 2008 Jul; 19(7):2870-5. PubMed ID: 18448670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.